These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38964465)

  • 1. Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming.
    Pavlenko T; Cunha PS; Oliveira MM
    Rev Port Cardiol; 2024 Jul; ():. PubMed ID: 38964465
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Aktas MK; Bennett AL; Younis A; Kutyifa V; Polonsky B; McNitt S; Zareba W; Rosero S; Goldenberg I
    Heart Rhythm O2; 2020 Jun; 1(2):77-82. PubMed ID: 34113861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry.
    Olshansky B; Atteya G; Cannom D; Heidbuchel H; Saarel EV; Anfinsen OG; Cheng A; Gold MR; Müssigbrodt A; Patton KK; Saxon LA; Wilkoff BL; Willems R; Dziura J; Li F; Brandt C; Simone L; Wilhelm M; Lampert R
    Heart Rhythm; 2019 Apr; 16(4):581-587. PubMed ID: 30389442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter-Defibrillator Programming Diffuse Into Clinical Practice?
    Varma N; Jones P; Wold N; Cronin E; Stein K
    J Am Heart Assoc; 2019 Feb; 8(3):e007392. PubMed ID: 30712432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes.
    Ananwattanasuk T; Tanawuttiwat T; Chokesuwattanaskul R; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K
    Heart Rhythm; 2020 Jul; 17(7):1101-1106. PubMed ID: 32058014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination use of an automatic anti-tachycardia pacemaker and an automatic implantable cardioverter-defibrillator in sustained recurrent ventricular tachycardia resistant to drugs].
    Benedini G; Caradonna E; Alfieri O; Visioli O
    G Ital Cardiol; 1989 Oct; 19(10):889-900. PubMed ID: 2612809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    J Arrhythm; 2016 Feb; 32(1):1-28. PubMed ID: 26949427
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.
    Tonko JB; Rinaldi CA
    Europace; 2022 Feb; 24(2):181-192. PubMed ID: 34453529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Arrhythm; 2019 Jun; 35(3):485-493. PubMed ID: 31293697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
    Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.